Members Only Content
Subscribe to get full access
Free Preview
Led by increases in its Diagnostics and Genomics business, the company increases guidance for 2022.
Upstart Recommendation Report Upstart Presentation Slides
Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to [...]
PubMatic just reported first quarter 2025 results. Aside from the headwinds of a DSP partner changing its bidding process, the [...]
